Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares - Bionomics (NASDAQ:BNOX), Cybin (AMEX:CYBN)
NY Mets owner billionaire Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management firm, again showing support for the biopharma sector.
Source: benzinga.com